Company page

Eloxx Pharmaceuticals, Inc.

Eloxx Pharmaceuticals, Inc. is a public company traded under the ticker ELOX in the American market, with a market capitalization of approximately $495.3 million. The company focuses on developing innovative therapies for genetic diseases caused by nonsense mutations. Eloxx aims to address significant unmet medical needs through its research and development efforts.